Morgan Stanley Vigil Neuroscience, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Morgan Stanley holds 13,091 shares of VIGL stock, worth $105,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,091

Previous 100,165 86.93%

Holding current value

$105,382

Previous $178,000 41.57%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$1.4 - $7.95 $121,903 - $692,238	-87,074 Reduced 86.93%	13,091 $104,000
Q1 2025 May 15, 2025	BUY	$1.71 - $3.03 $171,263 - $303,466	100,154 Added 910490.94%	100,165 $178,000
Q3 2024 May 14, 2025	SELL	$2.92 - $4.65 $57,903 - $92,209	-19,830 Reduced 99.94%	11 $0
Q3 2024 Nov 14, 2024	SELL	$2.92 - $4.65 $57,903 - $92,209	-19,830 Reduced 99.94%	11 $0
Q2 2024 May 14, 2025	BUY	$2.51 - $4.66 $49,773 - $92,407	19,830 Added 180272.73%	19,841 $79,000
Q2 2024 Oct 17, 2024	SELL	$2.51 - $4.66 $8,837 - $16,407	-3,521 Reduced 15.07%	19,841 $79,000
Q2 2024 Aug 14, 2024	SELL	$2.51 - $4.66 $8,837 - $16,407	-3,521 Reduced 15.07%	19,841 $79,000
Q1 2024 Oct 17, 2024	BUY	$2.68 - $3.63 $9,436 - $12,781	3,521 Added 17.75%	23,362 $79,000
Q1 2024 Aug 16, 2024	SELL	$2.68 - $3.63 $84,559 - $114,533	-31,552 Reduced 57.46%	23,362 $79,000
Q1 2024 May 15, 2024	SELL	$2.68 - $3.63 $84,559 - $114,533	-31,552 Reduced 57.46%	23,362 $79,000
Q4 2023 Aug 16, 2024	BUY	$2.97 - $8.6 $104,166 - $301,627	35,073 Added 176.77%	54,914 $185,000
Q4 2023 Feb 13, 2024	BUY	$2.97 - $8.6 $126,388 - $365,973	42,555 Added 344.32%	54,914 $185,000
Q3 2023 Nov 15, 2023	SELL	$4.8 - $9.92 $15,676 - $32,398	-3,266 Reduced 20.9%	12,359 $66,000
Q2 2023 Aug 14, 2023	SELL	$8.11 - $10.54 $346,451 - $450,258	-42,719 Reduced 73.22%	15,625 $146,000
Q1 2023 May 15, 2023	BUY	$8.77 - $12.7 $431,940 - $625,500	49,252 Added 541.71%	58,344 $571,000
Q4 2022 Feb 14, 2023	BUY	$8.74 - $15.99 $78,327 - $143,302	8,962 Added 6893.85%	9,092 $113,000
Q3 2022 Nov 14, 2022	SELL	$2.37 - $9.61 $7,602 - $30,828	-3,208 Reduced 96.11%	130 $1,000
Q2 2022 Oct 27, 2022	BUY	$2.23 - $7.81 $5,490 - $19,228	2,462 Added 281.05%	3,338 $7,000
Q2 2022 Aug 15, 2022	BUY	$2.23 - $7.81 $5,490 - $19,228	2,462 Added 281.05%	3,338 $7,000
Q1 2022 Oct 27, 2022	SELL	$7.03 - $17.29 $17,307 - $42,567	-2,462 Reduced 73.76%	876 $7,000
Q1 2022 May 13, 2022	BUY	$7.03 - $17.29 $6,158 - $15,146	876 New	876 $7,000

Others Institutions Holding VIGL

# of Institutions

Shares Held

38M

Call Options Held

Put Options Held

View Full List

About Vigil Neuroscience, Inc.

Ticker VIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,268,600
Market Cap $228M
Description
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...

More about VIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account